暂无数据
暂无内容
暂无数据
暂无数据
暂无数据
BMO Capital维持Acrivon Therapeutics的跑赢大盘
BMO Capital维持Acrivon Therapeutics的跑赢大盘
道琼斯14:12 (美东)
快讯 | BMO Capital维持Acrivon Therapeutics的跑赢大盘,将目标股价上调至25美元
Benzinga14:01 (美东)
在 ACR-368 试验数据乐观的情况下,目标价上涨 Acrivon Therapeutics 的评级
TipRanks04/26 07:20 (美东)
快讯 | Acrivon Therapeutics Inc:BMO将目标价格从18美元上调至25美元
Reuters04/26 07:01 (美东)
Acrivon Therapeutics:令人印象深刻的临床结果和市场潜力强劲买入
TipRanks04/25 12:46 (美东)
派珀·桑德勒维持 Acrivon Therapeutics 处于超重状态
派珀·桑德勒维持 Acrivon Therapeutics 处于超重状态
道琼斯04/25 09:04 (美东)
Jaguar8 : Twinning!
Trytosaveabit楼主 Jaguar8: Hehehe!
Jaguar8 : You really caught both similarities. Sharp!
Trytosaveabit楼主 Jaguar8: They are starting to separate! I would like them twinning again but both up up up! Hehehe
Jaguar8 Trytosaveabit楼主: Hahaha they decided to divorce then
暂无数据
暂无数据
JESSE JAMES8832 : i expeced so much better for this
JESSE JAMES8832 : maybe fill that gap to 6.62?
Trytosaveabit楼主 JESSE JAMES8832: Yup! But look at PCSA! It gets just a PT increase and flyin! This gets great news and a PT increase and dud? Hehehe
Trytosaveabit楼主 JESSE JAMES8832: It might try?